Authors : Kiruthiga O. B.; Mahalakshmi M.; Archana B.; Senthilkumar N.

Volume/Issue : Volume 10 - 2025, Issue 9 - September

Google Scholar : https://tinyurl.com/4pjzu9yc

Scribd : https://tinyurl.com/3bp3xn4w

DOI : https://doi.org/10.38124/ijisrt/25sep499

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : The rare, non-atherosclerotic, segmental inflammatory disease, Thromboangiitis obliterans (TAO), commonly referred to as Buerger's disease, mostly affects the medium and small arteries and veins in the extremities. Although recent epidemiological trends indicate an increase in instances among women due to rising smoking prevalence, it is strongly linked to tobacco use, especially among young male smokers. Distal extremity ischemia, rest pain, skin discoloration, ulceration, and gangrene are clinical manifestations of the condition, which frequently results in limb amputation if left untreated. The "corkscrew" collateral arteries shown on imaging are a crucial diagnostic feature, with illness preserving bigger vessels and visceral organs. Although the exact cause is unknown, environmental, genetic, and immunologic factors—particularly tobacco-induced endothelium dysfunction—play significant roles. In order to rule out mimicking illnesses, the diagnosis is made using clinical criteria, such as Shionoya's criteria, in conjunction with imaging and laboratory testing. The only treatment that has been shown to stop the progression of the disease is quitting smoking. Analgesics, prostaglandin analogs, vasodilators, and antiplatelet medicines are examples of adjunctive medical therapy. In more advanced cases, surgical procedures such as sympathectomy, spinal cord stimulation, the Ilizavor’s technique, and cell treatments employing bone marrow-derived mononuclear cells show promise. Mortality is still low despite the disease's severity, but ischemia agony and limb loss cause a high rate of morbidity. Improving patient outcomes still mostly depends on early diagnosis and rigorous smoke abstinence.

References :

1. Mills Sr, Joseph L. "Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy." Seminars in vascular surgery. Vol. 16. No. 3. WB Saunders, 2003
2. Vijayakumar, Abhishek, Rahul Tiwari, and Vinod Kumar Prabhuswamy. "Thromboangiitis obliterans (Buerger’s disease)—current practices." International journal of inflammation 2013.1 (2013): 156905.
3. Klein-Weigel, Peter, et al. "Buerger’s disease: providing integrated care." Journal of multidisciplinary healthcare (2016): 511-518.
4. Huh, Seung. "Buerger's Disease." Korean J Vasc Endovasc Surg 21.2 (2005): 200-205.
5. Zheng, Ping, and WanChao Wang. "Etiology and Pathogenesis of Buerger’s Disease." Probing Selected Autoimmune Diseases for Focused Perspectives. IntechOpen, 2024.
6. Tanaka, Kenzo. "Pathology and pathogenesis of Buerger's disease." International journal of cardiology 66 (1998): S237-S242.
7. Tanaka, Kenzo. "Pathology and pathogenesis of Buerger's disease." International journal of cardiology 66 (1998): S237-S242.
8. Arkkila, Perttu ET. "Thromboangiitis obliterans (Buerger's disease)." Orphanet journal of rare diseases 1 (2006): 1-5.
9. Modaghegh, Mohammad-Hadi Saeed, and Shirin Saberianpour. "Buerger’s Disease: A Bench-to-Bedside Review." Iran J Vasc Surg Endovasc Ther http://ijvset. gums. ac. ir 1.1 (2021).
10. Moniruddin, A. E. M., Hamida Begum, and Khairun Nahar. "Buerger's Disease (Thromboangitis obliterans): An Update." Medicine Today 23.1 (2011): 51-54.
11. Frank, Michael, and Jean-Noel Fiessinger. "Thromboangiitis obliterans (Buerger’s disease)." Oxford Textbook of: 507.
12. Benedetti-Valentini, Fabrizio, et al. "Buerger’s Disease of the Lower Extremities." Vascular Surgery. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. 471-478.
13. Park, Ui-Jun, and Dong-Ik Kim. "Thromoboagiitis obliterans (TAO)." International Journal of Stem Cells 3.1 (2010): 1-7.
14. LaTONA, S. R., and F. A. Y. LeFEVRE. "Thromboangiitis obliterans." Cleveland Clinic Quarterly 15 (1948): 12.
15. Qaja, Erion, Erind Muco, and Muhammad F. Hashmi. "Buerger disease." (2017).
16. Vijayakumar A, Tiwari R, Kumar Prabhuswamy V. Thromboangiitis Obliterans (Buerger's Disease)-Current Practices. Int J Inflam. 2013; 2013:156905. doi: 10.1155/2013/156905. Epub 2013 Sep 11. PMID: 24102033; PMCID: PMC3786473
17. T. Sasajima, Y. Kubo, M. Inaba, K. Goh, N. Azuma, “Role of infrainguinal bypass in Buerger's disease: An eighteen-year experience”. European Journal of Vascular and Endovascular Surgery Volume 13, Issue 2, February 1997, Pages 186-192.